31st Annual North American Cystic Fibrosis Conference

W13 - W13: CLIN: Pulmonary Abstracts

Nov 3, 2017 2:00pm ‐ Nov 3, 2017 3:20pm


Description

This workshop will provide attendees with an overview of various factors that may affect pulmonary outcomes in CF. Topics will include the CF microbiome, effects of azithromycin, pulmonary exacerbations and real world experience with CFTR modulators. The session will include information applicable to both pediatric and adult CF care.

Learning Objectives:

  1. Analyze important respiratory health issues related to the microbiome.
  2. Review benefits and risks of azithromycin use in CF.
  3. Summarize the consequences of lack of recovery from pulmonary exacerbations and new data on effectiveness of lumacaftor/ivacaftor.

Workshop Chair(s):

  • Raksha Jain, M.D., M.Sc., Associate Professor
  • Thomas Lahiri, M.D., Director, Pediatric Pulmonology, University of Vermont Children's Hospital

Workshop Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content